approval
saveWINREVAIR (SOTATERCEPT-CSRK) — FDA approval
community read0 votes
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approval— FDA approvalOct 15, 2025
- approvalpembrolizumab: KEYTRUDA (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalNov 21, 2025
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalSep 19, 2025
- approval(berahyaluronidase alfa + pembrolizumab): KEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approvalSep 19, 2025
- approvalsotatercept: WINREVAIR (SOTATERCEPT-CSRK) — FDA approvalDec 8, 2025
comments(0)
5-min edit window · permanent after that